New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. It operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and bone; and tertiary and second-level hospitals. The company is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Shenqi Schisandra tablets, Maiping tablets, Qianlieantong tablets, and Gongzuoning capsules. In addition, it engages in Chinese herbal medicine cultivation; technology development and consultation; investment management and consulting; asset, and industrial investment; retail business; wholesale trading activities; and provision of resident services.
